Clinical Trial Update: Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) [Phase 3]

View source ↗

Summary

PLANETRA, a Phase 3 trial evaluating CT-P13 in rheumatoid arthritis, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CT-P13 (infliximab biosimilar)

Snippet

Sponsor: Celltrion | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED